Skip to main content
Year archive

Keeps Biopharma Inc. — 2024 filings

All 32 regulatory filings released by Keeps Biopharma Inc. (256940) in 2024, sourced directly from the official regulator.

32 Filings
2024 Period
2024 filings (32)
Filing Released Lang
M&A Activity
2024-12-20 Korean
Share Issue/Capital Change
2024-12-19 Korean
Delisting Announcement
2024-12-18 Korean
M&A Activity
2024-12-18 Korean
Delisting Announcement
2024-12-18 Korean
Notice of Dividend Amount
2024-12-12 Korean
Capital/Financing Update
2024-11-27 Korean
Interim / Quarterly Report 9M 2024
2024-11-14 Korean
M&A Activity
2024-11-13 Korean
Director's Dealing
2024-11-05 Korean
Interim / Quarterly Report H1 2024
2024-08-14 Korean
Capital/Financing Update
2024-08-13 Korean
M&A Activity
2024-07-17 Korean
Regulatory Filings
2024-07-09 Korean
M&A Activity
2024-06-28 Korean
M&A Activity
2024-06-27 Korean
Interim / Quarterly Report Q1 2024
2024-05-14 Korean
Major Shareholding Notification
2024-04-03 Korean
Director's Dealing
2024-04-03 Korean
Declaration of Voting Results & Voting Rights Announcements
2024-03-29 Korean
Capital/Financing Update
2024-03-29 Korean
AGM Information
2024-03-22 Korean
Proxy Solicitation & Information Statement
2024-03-22 Korean
Audit Report / Information FY 2023
2024-03-21 Korean
Audit Report / Information FY 2023
2024-03-21 Korean
AGM Information
2024-03-14 Korean
Earnings Release FY 2023
2024-03-14 Korean
AGM Information
2024-03-14 Korean
Proxy Solicitation & Information Statement
2024-03-14 Korean
Proxy Solicitation & Information Statement
2024-03-14 Korean
Regulatory Filings
2024-01-31 Korean
Major Shareholding Notification
2024-01-03 Korean